27. Future perspectives for Tay-Sachs disease

This publication has 26 references indexed in Scilit:

• Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure
  American Journal of Medical Genetics, 2001
• Accelerated transport and maturation of lysosomal α–galactosidase A in Fabry lymphoblasts by an enzyme inhibitor
  Nature Medicine, 1999
• Engraftable human neural stem cells respond to development cues, replace neurons, and express foreign genes
  Nature Biotechnology, 1998
• Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells
  Human Molecular Genetics, 1998
• Biology and potential strategies for the treatment of GM2 gangliosidoses
  Molecular Medicine Today, 1998
• Prenatal genetic carrier testing using triple disease screening.
  JAMA, 1997
• Identification of Candidate Active Site Residues in Lysosomal β-Hexosaminidase A
  Journal of Biological Chemistry, 1997
• Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA Oligonucleotide
  Science, 1996
• Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay-Sachs disease
  Mammalian Genome, 1995
• Preimplantation genetic diagnosis for Tay-Sachs disease: successful pregnancy after pre-embryo biopsy and gene amplification by polymerase chain reaction
  Fertility and Sterility, 1995